Public response to an anthrax attack: Reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source

Biosecurity and Bioterrorism

Volumn 9, Issue 3, 2011, Pages 239-250

  Steelfisher, Gillian ^a   Blendon, Robert ^a   Ross, Laura J ^b   Collins, Blanche C ^c   Ben Porath, Eran N ^d   Bekheit, Mark M ^a   Mailhot, Johanna R ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Social Science Research Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ATTITUDE TO HEALTH; BACILLUS ANTHRACIS; BIOLOGICAL ACCIDENT; BIOLOGICAL WARFARE; HUMAN; INTERVIEW; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; REVIEW; STATISTICS; TRUST; UNITED STATES;

ADOLESCENT; ADULT; ANTHRAX; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACILLUS ANTHRACIS; BIOHAZARD RELEASE; BIOTERRORISM; DISTRICT OF COLUMBIA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; NEW JERSEY; NEW YORK; PATIENT ACCEPTANCE OF HEALTH CARE; PUBLIC OPINION; TRUST; YOUNG ADULT;

BACILLUS ANTHRACIS;

EID: 80052502151     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2011.0005     Document Type: Review

References (49)

1. U. S. Department of Justice. Amerithrax Investigative Summary. http://www.justice.gov/amerithrax/docs/amxinvestigative-summary.pdf. Accessed October 4, 2010.
2. Hall MJ, Norwood AE, Ursano RJ, Fullerton CS. The psychological impacts of bioterrorism. Biosecur Bioterror 2003;1(2):139-144.
3. Stein BD, Tanielian TL, Eisenman DP, Keyser DJ, Burnam MA, Pincus HA. Emotional and behavioral consequences of bioterrorism: planning a public health response. Milbank Q 2004;82(3):413-455. (Pubitemid 39297503)
4. Cole LA. The Anthrax Letters: A Bioterrorism Expert Investigates the Attacks that Shocked America. New York, NY: Skyhorse Publishing; 2009.
5. Graham B, Talent J. Prevention of WMD Proliferation and Terrorism Report Card: An Assessment of the U. S. Government's Progress in Protecting the United States from Weapons of Mass Destruction Proliferation and Terrorism. http://dod reports.com/pdf/ada513786.pdf. Accessed July 21, 2011.
6. Pearson A. Fiscal year 2009 federal funding for bioweapons prevention and defense. http://www.armscontrolcenter.org/policy/biochem/articles/fy09- biodefense-funding/. Accessed October 4, 2010.
7. Zaric GS, Bravata DM, Cleophas Holty JE, McDonald KM, Owens DK, Brandeau ML. Modeling the logistics of response to anthrax bioterrorism. Med Decis Making 2008;28(3):332-350. (Pubitemid 351713300)
8. Wein LM, Craft DL, Kaplan EH. Emergency response to an anthrax attack. Proc Natl Acad Sci U S A 2003;100(7):4346-4351. (Pubitemid 36418205)
9. Blank S, Moskin LC, Zucker JR. An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg Infect Dis 2003;9(6):615-622. (Pubitemid 36676353)
10. Sandman PM. Crisis communication best practices: some quibbles and additions. Journal of Applied Communication Research 2006;34(3):257-262. (Pubitemid 43970531)
11. Rinchiuso-Hasselmann A, Starr DT, McKay RL, Medina E, Raphael M. Public compliance with mass prophylaxis guidance. Biosecur Bioterror 2010;8(3):255-263.
12. Williams JL, Noviello SS, Griffith KS, et al. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis 2002;8(10):1133-1137. (Pubitemid 35257006)
13. Jefferds M, Laserson K, Fry A, et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, DC, 2001. Emerg Infect Dis 2002;8(10):1138-1144. (Pubitemid 35257007)
14. Shepard CW, Soriano-Gabarro M, Zell ER, et al. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis 2002;8(10):1124-1132. (Pubitemid 35257005)
15. Stein BD, Tanielian TL, Ryan GW, Rhodes HJ, Young SD, Blanchard JC. A bitter pill to swallow: nonadherence with prophylactic antibiotics during the anthrax attacks and the role of private physicians. Biosecur Bioterror 2004;2(3):175-185.
16. Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor-Clark K. The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis 2004;38(7):925-931. (Pubitemid 38457197)
17. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med 2010;362(22):e65.
18. Lasker RD. Redefining Readiness: Terrorism through the Eyes of the Public. New York: New York Academy of Medicine; 2004. http://www. redefiningreadiness.net/pdf/Redefining ReadinessStudy.pdf. Accessed October 4, 2010.
19. Meredith LS, Eisenman DP, Rhodes H, Ryan G, Long A. Trust influences public response to health messages during a bioterrorist event. J Health Commun 2007;12:217-232. (Pubitemid 46752416)
20. Cordasco KM, Eisenman DP, Glik DC, Golden JF. 'They blew the levee': distrust of authorities among Hurricane Katrina evacuees. J Health Care Poor Underserved 2007;18(2):277-282.
21. Paek HJ, Hilyard K, Freimuth VS, Barge JK, Mindlin M. Public support for government actions during a flu pandemic: lessons learned from a statewide survey. Health Promot Pract 2008;9(4 Suppl):60S-72S.
22. Blendon RJ, Donelan K, Knox RA. Public opinion and AIDS. Lessons for the second decade. JAMA 1992;267(7):981-986.
23. Wray R, Jupka K. What does the public want to know in the event of a terrorist attack using plague? Biosecur Bioterror 2004;2(3):208-215.
24. Covello VT, Peters RG, Wojtecki JG, Hyde RC. Risk communication, the West Nile virus epidemic, and bioterrorism: responding to the communication challenges posed by the intentional or unintentional release of a pathogen in an urban setting. J Urban Health 2001;78(2):382-391. (Pubitemid 32545540)
25. DiGiovanni C, Conley J, Chiu D, Zaborski J. Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak. Biosecur Bioterror 2004;2(4):265-272.
26. Pollard WE. Public perceptions of information sources concerning bioterrorism before and after anthrax attacks: an analysis of national survey data. J Health Commun 2003;8(Suppl 1):93-103; discussion 148-151.
27. Blendon RJ, Benson JM, Desroches CM, Weldon KJ. Using opinion surveys to track the public's response to a bioterrorist attack. J Health Commun 2003;8(Suppl 1):83-92; discussion 148-151.
28. U. S. Centers for Disease Control and Prevention. Cities Readiness Initiative Guidance. http://www.bt.cdc.gov/cri/. Accessed October 5, 2010.
29. U. S. Centers for Disease Control and Prevention. Strategic National Stockpile. http://www.bt.cdc.gov/stockpile/. Accessed October 5, 2010.
30. Bartlett JG, Inglesby TV Jr, Borio L. Management of anthrax. Clin Infect Dis 2002;35(7):851-858.
31. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281(18):1735-1745. (Pubitemid 29226485)
32. Steelfisher GK, Blendon RJ, Bekheit MM, et al. Parental attitudes and experiences during school dismissals related to 2009 influenza A (H1N1)-United States, 2009. MMWR Morb Mortal Wkly Rept 2010 Sept 10; 59 (35):1131-1134.
33. Keeter S, Kennedy C, Dimock M, Best J, Craighill P. Gauging the impact of growing nonresponse on estimates from a national RDD telephone survey. Public Opin Q 2006;70:759-779.
34. U. S. Census Bureau. Current Population Survey 2009. http://www.census. gov/cps/. Accessed October 18, 2010.
35. U. S. Census Bureau. American Community Survey 2009. http://www.census. gov/acs/www/. Accessed October 18, 2010.
36. Blumberg SJ, Luke JV. Wireless Substitution: Early Release of Estimates From the National Health Interview Survey, July-December 2008. http://www.cdc.gov/nchs/data/nhis/earlyrelease/wireless200905.htm. Accessed October 18, 2010.
37. Weaver D. Issue salience and public opinion: are there consequences of agenda-setting? Int J Public Opin Res 1991;3(1):53-86.
38. Epstein L, Segal JA. Measuring issue salience. Am J Political Sci 2000;44(1):66-83.
39. Krosnick JA. The role of attitude importance in social evaluation: a study of policy preferences, presidential candidate evaluations, and voting behavior. J Personality Social Psychol 1988;55(2):196-210.
40. Fournier P, Blais A, Nadeau R, Gidengil E, Nevitte N. Issue importance and performance voting. Political Behavior 2003;25(1):51-67.
41. SteelFisher GK, Blendon RJ, Bekheit MM, et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol 2011;204(6 Suppl 1):S116-S123.
42. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc Sci Med 2005;61(9):2038-2046. (Pubitemid 41112301)
43. Bradsher K. Now, the SARS emotional toll. New York Times June 4, 2003. http://query.nytimes.com/gst/fullpage.html?res= 9A07E1DA1030F937A35755C0A9659C8B63&partner=rssnyt&emc= rss&pagewanted=all. Accessed October 13, 2010.
44. Blendon RJ, DesRoches CM, Cetron MS, Benson JM, Meinhardt T, Pollard W. Attitudes toward the use of quarantine in a public health emergency in four countries. Health Aff 2006 Mar-Apr; 25(2):w15-25. (Pubitemid 43529592)
45. Taylor-Clark K, Blendon RJ, Zaslavsky A, Benson J. Confidence in crisis? Understanding trust in government and public attitudes toward mandatory state health powers. Biosecur Bioterror 2005;3(2):138-147. (Pubitemid 43971724)
46. Blendon RJ, DesRoches CM, Benson JM, Herrmann MJ, Taylor-Clark K, Weldon KJ. The public and the smallpox threat. N Engl J Med 2003;348(5):426-432. (Pubitemid 36159361)
47. Person B, Sy F, Holton K, Govert B, Liang A. Fear and stigma: the epidemic within the SARS outbreak. Emerg Infect Dis 2004;10(2):358-363. (Pubitemid 38176986)
48. Blumenshine P, Reingold A, Egerter S, Mockenhaupt R, Braveman P, Marks J. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis 2008;14(5):709-715. (Pubitemid 351838632)
49. Crouse Quinn S. Crisis and emergency risk communication in a pandemic: a model for building capacity and resilience of minority communities. Health Promot Pract 2008;9(4 Suppl):18S-25S.